Suppr超能文献

单次口服剂量后乙基吗啡的生物转化与药代动力学

Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose.

作者信息

Aasmundstad T A, Xu B Q, Johansson I, Ripel A, Bjørneboe A, Christophersen A S, Bodd E, Mørland J

机构信息

National Institute of Forensic Toxicology, Oslo, Norway.

出版信息

Br J Clin Pharmacol. 1995 Jun;39(6):611-20. doi: 10.1111/j.1365-2125.1995.tb05720.x.

Abstract
  1. The pharmacokinetics of ethylmorphine after administration of a single dose of the cough mixture Cosylan were investigated in 10 healthy subjects. 2. The median urinary recovery of ethylmorphine and measured metabolites was 77% over 48 h. The median tmax of unchanged ethylmorphine was 45 min, and the terminal elimination t1/2 was 2 h. Ethylmorphine-6-glucuronide was found to be the major metabolite. 3. Two subjects had significantly lower urinary recovery (0.48 h) of morphine and morphine-glucuronides than the remainder. Furthermore, these two had urinary metabolic ratios (MRO) and partial metabolic clearances (CLmO) for O-deethylation of ethylmorphine tentatively classifying them phenotypically as poor metabolisers of the debrisoquine/sparteine type. 4. Genotyping for cytochrome P450 (CYP) 2D6 alleles revealed five homozygote (wt/wt) and five heterozygote subjects. Two subjects phenotypically classified as poor metabolisers were genotypically CYP2D6A/wt and CYP2D6D/wt, respectively. 5. Serum and urine samples taken more than 8 and 24 h after administration of ethyl-morphine respectively, contained morphine and morphine-glucuronides, but no ethylmorphine, ethylmorphine-6-glucuronide or (serum only) norethylmorphine. Norethylmorphine could be detected after hydrolysis of urine samples in all subjects. The urinary recovery of the active metabolites morphine and morphine-6-glucuronide after administration of ethylmorphine varied by a factor of 9 between individuals. 6. The wide variation in recovery of morphine and morphine-glucuronides after oral administration of ethylmorphine could not be explained simply by a difference in CYP2D6 genotype. Constitutional variation in other enzymatic pathways involved in ethylmorphine metabolism is probably crucial. Ratios of morphine to parent drug cannot be used to distinguish the source of morphine after administration of ethylmorphine. Norethylmorphine should be included in urine assays for opiates in forensic toxicology, and no firm conclusions about the source of morphine are possible based on serum samples obtained more than 24 h after drug administration.
摘要
  1. 在10名健康受试者中研究了单剂量止咳合剂Cosylan给药后乙基吗啡的药代动力学。2. 乙基吗啡及其代谢产物在48小时内的尿回收率中位数为77%。未变化的乙基吗啡的tmax中位数为45分钟,终末消除t1/2为2小时。乙基吗啡-6-葡萄糖醛酸被发现是主要代谢产物。3. 两名受试者的吗啡及吗啡葡萄糖醛酸的尿回收率(0.48小时)显著低于其余受试者。此外,这两名受试者的乙基吗啡O-去乙基化的尿代谢率(MRO)和部分代谢清除率(CLmO)初步将其表型分类为地布卡因/鹰爪豆碱型慢代谢者。4. 细胞色素P450(CYP)2D6等位基因的基因分型显示有5名纯合子(wt/wt)受试者和5名杂合子受试者。两名表型分类为慢代谢者的受试者的基因分型分别为CYP2D6A/wt和CYP2D6D/wt。5. 分别在乙基吗啡给药后8小时和24小时以上采集的血清和尿液样本中含有吗啡和吗啡葡萄糖醛酸,但不含乙基吗啡、乙基吗啡-6-葡萄糖醛酸或(仅血清中)去甲乙基吗啡。在所有受试者的尿液样本水解后均可检测到去甲乙基吗啡。乙基吗啡给药后活性代谢产物吗啡和吗啡-6-葡萄糖醛酸的尿回收率在个体间相差9倍。6. 口服乙基吗啡后吗啡和吗啡葡萄糖醛酸回收率的广泛差异不能简单地用CYP2D6基因型的差异来解释。参与乙基吗啡代谢的其他酶途径的体质差异可能至关重要。吗啡与母体药物的比率不能用于区分乙基吗啡给药后吗啡的来源。在法医毒理学中,尿液鸦片类药物检测应包括去甲乙基吗啡,且根据给药后24小时以上采集的血清样本无法对吗啡的来源得出确切结论。

相似文献

9
Death of a 10-month-old boy after exposure to ethylmorphine.一名10个月大男童接触乙基吗啡后死亡。
J Forensic Sci. 2010 Mar 1;55(2):551-3. doi: 10.1111/j.1556-4029.2009.01294.x. Epub 2010 Feb 11.
10
Ethylmorphine metabolism in isolated rat hepatocytes.
Pharmacol Toxicol. 1993 Jul;73(1):35-40. doi: 10.1111/j.1600-0773.1993.tb01954.x.

引用本文的文献

1
Predicted Biological Activity of Purchasable Chemical Space.可购买化学空间的预测生物活性。
J Chem Inf Model. 2018 Jan 22;58(1):148-164. doi: 10.1021/acs.jcim.7b00316. Epub 2017 Dec 29.

本文引用的文献

2
The in vivo liberation of morphine from codeine in man.
J Pharmacol Exp Ther. 1954 Jun;111(2):142-6.
4
Different biotransformation of morphine in isolated liver cells from guinea pig and rat.
Biochem Pharmacol. 1993 Sep 14;46(6):961-8. doi: 10.1016/0006-2952(93)90659-k.
7
Parameters affecting the yield of DNA from human blood.影响从人血中提取DNA产量的参数。
Anal Biochem. 1987 Sep;165(2):294-9. doi: 10.1016/0003-2697(87)90272-7.
8
Morphine-6-glucuronide, a potent mu agonist.
Life Sci. 1987 Dec 28;41(26):2845-9. doi: 10.1016/0024-3205(87)90431-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验